A High Force of Plasmodium vivax Blood-Stage Infection Drives the Rapid Acquisition of Immunity in Papua New Guinean Children

Background When both parasite species are co-endemic, Plasmodium vivax incidence peaks in younger children compared to P. falciparum. To identify differences in the number of blood stage infections of these species and its potential link to acquisition of immunity, we have estimated the molecular force of blood-stage infection of P. vivax (molFOB, i.e. the number of genetically distinct blood-stage infections over time), and compared it to previously reported values for P. falciparum. Methods P. vivax molFOB was estimated by high resolution genotyping parasites in samples collected over 16 months in a cohort of 264 Papua New Guinean children living in an area highly endemic for P. falciparum and P. vivax. In this cohort, P. vivax episodes decreased three-fold over the age range of 1–4.5 years. Results On average, children acquired 14.0 new P. vivax blood-stage clones/child/year-at-risk. While the incidence of clinical P. vivax illness was strongly associated with molFOB (incidence rate ratio (IRR) = 1.99, 95% confidence interval (CI95) [1.80, 2.19]), molFOB did not change with age. The incidence of P. vivax showed a faster decrease with age in children with high (IRR = 0.49, CI95 [0.38, 0.64] p<0.001) compared to those with low exposure (IRR = 0.63, CI95[0.43, 0.93] p = 0.02). Conclusion P. vivax molFOB is considerably higher than P. falciparum molFOB (5.5 clones/child/year-at-risk). The high number of P. vivax clones that infect children in early childhood contribute to the rapid acquisition of immunity against clinical P. vivax malaria.

[1]  D. Bates,et al.  Linear Mixed-Effects Models using 'Eigen' and S4 , 2015 .

[2]  Q. Bassat,et al.  Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age. , 2012, The Journal of infectious diseases.

[3]  Thomas A. Smith,et al.  Force of infection is key to understanding the epidemiology of Plasmodium falciparum malaria in Papua New Guinean children , 2012, Proceedings of the National Academy of Sciences.

[4]  F. Nosten,et al.  The First Plasmodium vivax Relapses of Life Are Usually Genetically Homologous , 2011, The Journal of infectious diseases.

[5]  Thomas A. Smith,et al.  Multiplicity and Diversity of Plasmodium vivax Infections in a Highly Endemic Region in Papua New Guinea , 2011, PLoS neglected tropical diseases.

[6]  N. White.  Determinants of relapse periodicity in Plasmodium vivax malaria , 2011, Malaria Journal.

[7]  P. Siba,et al.  Population Pharmacokinetics of Artemether, Lumefantrine, and Their Respective Metabolites in Papua New Guinean Children with Uncomplicated Malaria , 2011, Antimicrobial Agents and Chemotherapy.

[8]  W. Rojas,et al.  High genetic polymorphism of relapsing P. vivax isolates in northwest Colombia , 2011, Acta Tropica.

[9]  P. Siba,et al.  Characterization of Treatment Failure in Efficacy Trials of Drugs against Plasmodium vivax by Genotyping Neutral and Drug Resistance-Associated Markers , 2011, Antimicrobial Agents and Chemotherapy.

[10]  Thomas A. Smith,et al.  How Much Remains Undetected? Probability of Molecular Detection of Human Plasmodia in the Field , 2011, PloS one.

[11]  P. Siba,et al.  Pharmacokinetic Properties of Conventional and Double-Dose Sulfadoxine-Pyrimethamine Given as Intermittent Preventive Treatment in Infancy , 2011, Antimicrobial Agents and Chemotherapy.

[12]  P. Siba,et al.  Differential Patterns of Infection and Disease with P. falciparum and P. vivax in Young Papua New Guinean Children , 2010, PloS one.

[13]  I. Mueller,et al.  Comparison of Plasmodium falciparum allelic frequency distribution in different endemic settings by high-resolution genotyping , 2009, Malaria Journal.

[14]  Thomas A. Smith,et al.  Three different Plasmodium species show similar patterns of clinical tolerance of malaria infection , 2009, Malaria Journal.

[15]  I. Mueller,et al.  Strain-Specific Duffy Binding Protein Antibodies Correlate with Protection against Infection with Homologous Compared to Heterologous Plasmodium vivax Strains in Papua New Guinean Children , 2009, Infection and Immunity.

[16]  Thomas A. Smith,et al.  High sensitivity detection of Plasmodium species reveals positive correlations between infections of different species, shifts in age distribution and reduced local variation in Papua New Guinea , 2009, Malaria Journal.

[17]  P. Siba,et al.  A trial of combination antimalarial therapies in children from Papua New Guinea. , 2008, The New England journal of medicine.

[18]  M. Fay,et al.  Protection Induced by Plasmodium falciparum MSP142 Is Strain-Specific, Antigen and Adjuvant Dependent, and Correlates with Antibody Responses , 2008, PloS one.

[19]  Kevin Marsh,et al.  Immunity to malaria: more questions than answers , 2008, Nature Immunology.

[20]  A. Sakuntabhai,et al.  Longitudinal study of Plasmodium falciparum and Plasmodium vivax in a Karen population in Thailand , 2008, Malaria Journal.

[21]  D. Conway,et al.  Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria , 2008, Infection and Immunity.

[22]  I. Mueller,et al.  The risk of malarial infections and disease in Papua New Guinean children. , 2007, The American journal of tropical medicine and hygiene.

[23]  J. Carlton,et al.  Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. , 2007, The Journal of infectious diseases.

[24]  J. Kazura,et al.  Changing patterns of Plasmodium blood-stage infections in the Wosera region of Papua New Guinea monitored by light microscopy and high throughput PCR diagnosis. , 2006, The American journal of tropical medicine and hygiene.

[25]  Simon N. Wood.  Generalized Additive Models: An Introduction with R , 2006 .

[26]  T. Ishizaki,et al.  The disposition of oral amodiaquine in Papua New Guinean children with falciparum malaria. , 2005, British journal of clinical pharmacology.

[27]  M. Alpers,et al.  Polymerase chain reaction diagnosis and the changing pattern of vector ecology and malaria transmission dynamics in papua new Guinea. , 2004, The American journal of tropical medicine and hygiene.

[28]  Kevin Marsh,et al.  The role of antibodies to Plasmodium falciparum-infected-erythrocyte surface antigens in naturally acquired immunity to malaria. , 2002, Trends in microbiology.

[29]  W E Collins,et al.  A retrospective examination of secondary sporozoite- and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity following secondary infection. , 1999, American Journal of Tropical Medicine and Hygiene.

[30]  M Tanner,et al.  The epidemiology of multiple Plasmodium falciparum infections. 11. Premunition in Plasmodium falciparum infection : Insights from the epidemiology of multiple infections , 1999 .

[31]  Chris Newbold,et al.  Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa , 1997, The Lancet.

[32]  C. Newbold,et al.  The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[33]  R. Coppel,et al.  Diversity of the vaccine candidate AMA-1 of Plasmodium falciparum. , 1996, Molecular and biochemical parasitology.

[34]  J. Adams,et al.  Natural variation within the principal adhesion domain of the Plasmodium vivax duffy binding protein , 1994, Infection and immunity.

[35]  B. Fenton,et al.  Structural and antigenic polymorphism of the 35- to 48-kilodalton merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum , 1991, Molecular and cellular biology.

[36]  J. Sattabongkot,et al.  Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax. , 1989, Science.

[37]  K. Tanabe,et al.  Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum. , 1987, Journal of molecular biology.

[38]  P. Boreham,et al.  The relationship of host size to feeding by mosquitoes of the Anopheles gambiae Giles complex (Diptera: Culicidae) , 1980 .

[39]  J. Meuwissen.  IMMUNITY IN MALARIA , 1944, Nederlands tijdschrift voor geneeskunde.

[40]  R. Koch.  Dritter Bericht über die Thätigkeit der Malaria-Expedition , 1900 .

[41]  R. Koch.  Zweiter Bericht über die Thätigkeit der Malariaexpedition , 1900 .

[42]  P. Vounatsou,et al.  Area effects of bednet use in a malaria-endemic area in Papua New Guinea. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[43]  K. Mendis,et al.  Patterns of acquired anti-malarial immunity in Sri Lanka. , 1994, Memorias do Instituto Oswaldo Cruz.

[44]  G M Jeffery,et al.  Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium. , 1966, Bulletin of the World Health Organization.

[45]  W H TALIAFERRO,et al.  Acquired immunity in malaria. , 1948, Abstracts. International Congress on Tropical Medicine and Malaria.